20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

The Crucial Role of Oclacitinib Maleate in Modern Immunotherapy

At NINGBO INNO PHARMCHEM CO.,LTD., we understand the critical role that high-quality intermediates play in advancing scientific discovery. One such compound making significant strides in the field of advanced therapeutics is Oclacitinib Maleate, particularly recognized for its function as an organic synthetic intermediate for PD-1 inhibitors. This molecule is instrumental in the development of novel treatments within immunotherapy and antineoplastic drug research.

The scientific community is increasingly focused on leveraging the body's own immune system to combat complex diseases. PD-1 inhibitors, a class of drugs that modulate immune responses, have shown remarkable promise. Oclacitinib Maleate, with its precise chemical structure and high purity, serves as a foundational component for synthesizing these sophisticated compounds. Its CAS number, 1208319-27-0, is a key identifier for researchers seeking reliable sources for their critical experiments.

Our commitment to providing superior pharmaceutical chemicals means that researchers can depend on the quality of Oclacitinib Maleate for their studies. This reliability is essential when exploring the mechanisms of PD-1 inhibition, which is central to activating T-cell immune responses. By blocking specific pathways, these therapies enhance the body's ability to identify and neutralize harmful cells, marking a significant advancement in cancer treatment and other immune-related conditions. The pursuit of effective antineoplastic drug immunotherapy relies heavily on the availability of such well-characterized intermediates.

The application of Oclacitinib Maleate extends beyond just synthesis; it represents a gateway to understanding and manipulating complex biological pathways. As a key organic synthetic intermediate, it empowers scientists to delve deeper into the intricacies of immune regulation, paving the way for more targeted and effective treatment strategies. The continuous demand for innovative solutions in healthcare underscores the importance of supplying these foundational materials, enabling breakthroughs that can ultimately improve patient outcomes.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Chrysin's Diverse Anticancer Mechanisms: From Lung to Melanoma

Next: Understanding PD-1 Inhibitors: The Role of Oclacitinib Maleate

All Rights Reserved